题名 | Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis |
作者 | |
通讯作者 | Xu, Yuzhong; Zhang, Guoliang |
发表日期 | 2023-06-01
|
DOI | |
发表期刊 | |
ISSN | 2150-7511
|
卷号 | 14期号:4 |
摘要 | ["It is urgent to develop novel treatment strategies against drug-resistant TB, and HDT provides a promising approach to fight drug-resistant TB by repurposing old drugs. Our studies demonstrate, for the first time, that BBM, an FDA-approved drug, not only potently inhibits intracellular drug-sensitive Mtb growth but also restricts drug-resistant Mtb by promoting macrophage autophagy. Mechanistically, BBM activates macrophage autophagy by regulating the ROS/Ca2+ axis. In conclusion, BBM could be considered as an HDT candidate and may contribute to improving the outcomes or shortening the treatment course of drug-resistant TB.","Drug-resistant tuberculosis (TB) poses a major threat to global TB control; consequently, there is an urgent need to develop novel anti-TB drugs or strategies. Host-directed therapy (HDT) is emerging as an effective treatment strategy, especially for drug-resistant TB. This study evaluated the effects of berbamine (BBM), a bisbenzylisoquinoline alkaloid, on mycobacterial growth in macrophages. BBM inhibited intracellular Mycobacterium tuberculosis (Mtb) growth by promoting autophagy and silencing ATG5, partially abolishing the inhibitory effect. In addition, BBM increased intracellular reactive oxygen species (ROS), while the antioxidant N-acetyl-L-cysteine (NAC) abolished BBM-induced autophagy and the ability to inhibit Mtb survival. Furthermore, the increased intracellular Ca2+ concentration induced by BBM was regulated by ROS, and BAPTA-AM, an intracellular Ca2+-chelating agent, could block ROS-mediated autophagy and Mtb clearance. Finally, BBM could inhibit the survival of drug-resistant Mtb. Collectively, these findings provide evidence that BBM, a Food and Drug Administration (FDA)-approved drug, could effectively clear drug-sensitive and -resistant Mtb through regulating ROS/Ca2+ axis-mediated autophagy and has potential as an HDT candidate for TB therapy. IMPORTANCEIt is urgent to develop novel treatment strategies against drug-resistant TB, and HDT provides a promising approach to fight drug-resistant TB by repurposing old drugs. Our studies demonstrate, for the first time, that BBM, an FDA-approved drug, not only potently inhibits intracellular drug-sensitive Mtb growth but also restricts drug-resistant Mtb by promoting macrophage autophagy. Mechanistically, BBM activates macrophage autophagy by regulating the ROS/Ca2+ axis. In conclusion, BBM could be considered as an HDT candidate and may contribute to improving the outcomes or shortening the treatment course of drug-resistant TB."] |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 第一
; 通讯
|
资助项目 | National Key Research and Development Plan[2021YFA1300902]
; National Natural Science Foundation of China["82170009","82100013"]
; Guangdong Scientific and Technological Foundation["2019B1515120041","2020B1111170014"]
; Guangxi Scientific and Technological Foundations[AA22096027]
; Shenzhen Scientific and Technological Foundations["KCXFZ20211020163545004","KCXFZ202002011007083","JCYJ20190809104205706","JCYJ20180228162321234"]
|
WOS研究方向 | Microbiology
|
WOS类目 | Microbiology
|
WOS记录号 | WOS:001023845600001
|
出版者 | |
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:4
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/549368 |
专题 | 南方科技大学第二附属医院 南方科技大学第一附属医院 |
作者单位 | 1.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Guangdong Prov Clin Res Ctr TB, Shenzhen, Peoples R China 2.Guangzhou Med Univ, Guangzhou, Peoples R China 3.Shenzhen Univ, Baoan Peoples Hosp Shenzhen, Affiliated Hosp 2, Dept Clin Lab, Shenzhen, Peoples R China 4.Guangxi Chest Hosp, Dept TB, Liuzhou, Peoples R China |
第一作者单位 | 南方科技大学第二附属医院; 南方科技大学第一附属医院 |
通讯作者单位 | 南方科技大学第二附属医院; 南方科技大学第一附属医院 |
第一作者的第一单位 | 南方科技大学第二附属医院; 南方科技大学第一附属医院 |
推荐引用方式 GB/T 7714 |
Zhang, Su,Zhou, Xuefeng,Ou, Min,et al. Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis[J]. MBIO,2023,14(4).
|
APA |
Zhang, Su.,Zhou, Xuefeng.,Ou, Min.,Fu, Xiangdong.,Lin, Qiao.,...&Zhang, Guoliang.(2023).Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis.MBIO,14(4).
|
MLA |
Zhang, Su,et al."Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca2+ axis".MBIO 14.4(2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论